Reference
Reference TypeLiterature
TitleImpact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis.
AuthorsF F Weichold; S Mueller; C Kortsik; W E Hitzler; M J Wulf; D M Hone; J C Sadoff; M J Maeurer
AffiliationsAeras Global TB Vaccine Foundation, Bethesda, MD, USA.
JournalGenes Immun
Year2007
AbstractChallenged by scattered understanding of protective immunity to Mycobacterium tuberculosis (MTB), we have mapped peptide epitopes to human leukocyte antigen (HLA)-A*0101, A*0201, A*1101, A*2402, B*0702, B*0801 and B*1501 of the secreted mycobacterial antigen Ag85B, a vaccine candidate that may be associated with immune protection. Affinity (ED(50)) and half-life (t(1/2), off-rate) analysis for individual peptide species on HLA-A and HLA-B molecules revealed binding ranges between 10(-3) and 10(-7) M. After selection of the best matches, major histocompatibility complex class I/peptide tetramer complexes were constructed to measure the CD8+ T-cell responses directly ex vivo in peripheral blood mononuclear cells (PBMC) derived from 57 patients with acute pulmonary tuberculosis. Three patterns of (allele-) specific CD8+ recognition were identified: (a). Focus on one dominant epitope with additional recognition of several subdominant T-cell epitopes (HLA-A*0301, A*2402, B*0801 and B*1501); (b). Co-dominant recognition of two distinct groups of peptides presented by HLA-B*0702; and (c). Diverse and broad recognition of peptides presented by HLA-A*0201. Peptides that bound with slow off-rates to class I alleles, that is HLA-A*0201, were associated with low frequency of CD8+ T cells in PBMCs from patients with tuberculosis. HLA-B alleles showed fast off-rates in peptide binding and restricted high numbers (up to 6%) of antigen-specific CD8+ T cells in patients with pulmonary tuberculosis.
Curation Last Updated2023-08-18 20:22:37
Epitope
Epitope ID5623
Chemical TypeLinear peptide
Linear SequenceAVYLLDGLR
Source Molecule NameAntigen 85-B precursor (85B) (Extracellular alpha-antigen) (Antigen 85 complex B) (Ag85B) (Mycolyl transferase 85B) (Fibronectin-binding protein B) (30 kDa extracellular protein)
Source OrganismMycobacterium tuberculosis
Starting Position75
Ending Position83
Epitope Reference Details
Epitope Structure DefinesExact Epitope
Epitope NameMTB Ag85 35-43
Reference Starting Position35
Reference Ending Position43
Location of Data in ReferenceTable 1
Immunization
Host OrganismHomo sapiens (human)
1st In Vivo Process
In Vivo Process TypeOccurrence of infectious disease
Disease Statetuberculosis
Disease StageAcute/Recent onset;OGMS:0000094
1st Immunogen
Epitope RelationSource Organism
Object TypeOrganism
OrganismMycobacterium tuberculosis
Immunogen Details
Immunogen Reference NameMycobacterium tuberculosis
Immunization Comments
Immunization CommentsPBMCs were collected from 57 MHC class I-typed individuals with active pulmonary tuberculosis.
T Cell Assay
Qualitative MeasurementPositive
Method/Techniquemultimer/tetramer
Measurement ofqualitative binding
Measurement Details
Quantitative measurement0.65
Number of Subjects Tested16
Number of Subjects Responded16
Response Frequency (%)100
Effector Cells
Effector Cell Tissue TypeBlood
Effector Cell TypeT cell CD8+
Effector Cell Culture ConditionsDirect Ex Vivo
MHC Allele
MHC Allele NameHLA-A*03:01
MHC Evidence CodeSingle allele present
Antigen
Epitope RelationEpitope
Chemical TypeLinear peptide
Linear SequenceAVYLLDGLR
Source Molecule NameAntigen 85-B precursor (85B) (Extracellular alpha-antigen) (Antigen 85 complex B) (Ag85B) (Mycolyl transferase 85B) (Fibronectin-binding protein B) (30 kDa extracellular protein)
Source OrganismMycobacterium tuberculosis
Starting Position75
Ending Position83
Antigen Details
Antigen Reference NameMTB Ag85 35-43
Assay Reference Details
Assay Comments by IEDB CuratorTetramer-reactive T cells were observed in patients with active TB. The predominant class I response directed against Ag85B in TB patients is HLA-B (highest frequency of tetramer-reactive T cells).
Location of Assay Data in ReferenceFigure 3